查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1575452

肺氣腫治療市場：按類型、治療方法方式、患者類型、護理環境、給藥途徑- 全球預測 2025-2030

Emphysema Treatment Market by Type (Inhalation Drugs, Intravenous Drugs, Oral Drugs), Treatment (Medications, Surgeries, Therapies), Patient Type, Care Settings, Route of Administration - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年肺氣腫治療市值為64億美元，預計到2024年將達到68.3億美元，複合年成長率為6.98%，預計到2030年將達到102.7億美元。

肺氣腫治療市場的範圍和定義涵蓋了旨在管理這種慢性且不可逆轉的肺部疾病的廣泛醫療干預措施，其主要特徵是氣囊受損和氣流阻塞。肺氣腫嚴重損害生活品質，因此需要進行治療以緩解症狀並改善呼吸功能。藥物治療方法（如支氣管擴張劑和皮質類固醇）和手術介入（如肺活量減少手術）均已應用。最終用途包括醫院、診所、家庭保健等。主要成長動力包括由於人口老化和污染水平上升而導致慢性阻塞性肺病（COPD）盛行率增加、藥物開發的進步以及患者對微創手術的偏好增加。然而，潛在的成長機會在於擴大新興市場的醫療基礎設施以及開拓新的治療方法，例如再生醫學和人工智慧技術支援的個人化治療計劃。解決市場限制的挑戰主要是由於嚴格的監管要求、與先進治療方法相關的高成本以及進行呼吸系統疾病臨床試驗的獨特複雜性。特定地區的經濟不穩定也可能抑制市場擴張。創新的研究和開發領域包括開發可監測呼吸系統健康的穿戴式技術、促進遠端患者管理的遠端醫療的進步以及實現早期診斷和客製化治療的生物標記物的發現。市場是動態的，人們非常關注技術進步和向以患者為中心的整體護理模式的轉變。希望發展業務的公司應該投資研發，以緩解挑戰並利用新機會。製藥公司、醫療保健提供者和技術公司之間的合作可以加速創新，並提高市場滲透率和患者治療效果。隨著市場在全球範圍內不斷擴張，關注具有成本效益且易於獲得的治療方案至關重要。

主要市場統計
基準年[2023] 64億美元
預測年份 [2024] 68.3億美元
預測年份 [2030] 102.7億美元
複合年成長率（%） 6.98%

市場動態：揭示快速發展的肺氣腫治療市場的關鍵市場洞察

供需的動態交互作用正在改變肺氣腫治療市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，並了解消費行為及其對製造成本的影響，並更清楚地了解對採購趨勢的影響。

  • 市場促進因素
    • 吸煙率上升和污染水平上升導致肺氣腫發生率上升
    • 促進肺氣腫早期發現和治療的診斷技術和技術的進步
    • 老年人口增多，老年人呼吸道疾病易感性高
    • 增加醫療支出和政府努力支持肺氣腫的先進治療方案
  • 市場限制因素
    • 由於新藥和器械嚴格的監管核准流程導致市場准入延遲；
    • 農村地區肺氣腫的認知和診斷率較低阻礙因素了市場成長
  • 市場機會
    • 肺氣腫治療越來越偏好微創手術治療
    • 對治療肺氣腫的先進標靶給藥系統的需求不斷成長
    • 早期發現肺氣腫的意識和篩檢計劃
  • 市場挑戰
    • 進入市場的新肺氣腫治療藥物面臨監管障礙和漫長的核准時間
    • 由於複雜的劑量要求，患者對規定治療方法的依從性較差

波特五力：開拓肺氣腫治療市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解肺氣腫治療市場的外部影響

外部宏觀環境因素在塑造肺氣腫治療市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助企業預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解肺氣腫治療市場的競爭狀況

肺氣腫治療市場的詳細市場佔有率分析可以對供應商的表現進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣肺氣腫治療市場供應商的績效評估

FPNV定位矩陣是評估肺氣腫治療市場供應商的關鍵工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了肺氣腫治療市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對肺氣腫治療市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 吸煙率的增加和空氣污染水平的上升導致肺氣腫的發生率增加
      • 促進肺氣腫早期發現和治療的診斷技術和技術的進步
      • 老年人口增加，老年人對呼吸道疾病的敏感度增加
      • 不斷上漲的醫療成本和政府支持肺氣腫先進治療方案的努力
    • 抑制因素
      • 新肺氣腫藥物和醫療設備的嚴格監管核准程序減緩了市場准入
      • 農村地區肺氣腫認知率和診斷率低阻礙市場成長
    • 機會
      • 微創手術治療在肺氣腫治療中越來越受歡迎
      • 對治療肺氣腫的標靶和先進藥物傳輸系統的需求不斷成長
      • 早期發現肺氣腫的意識提升和篩檢計劃
    • 任務
      • 新肺氣腫治療方法進入市場存在監管障礙和漫長的核准時間
      • 由於複雜的劑量要求，患者對規定治療方案的依從性較差
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章肺氣腫治療市場：依類型

  • 吸入器
    • 抗膽鹼能藥物
    • 長效BETA受體激動劑（LABA）
    • 短效BETA受體激動劑（SABA）
  • 靜脈注射藥物
  • 口服藥物
    • 皮質類固醇
    • 磷酸二酯酶 4 抑制劑（PDE4 抑制劑）

第7章 肺氣腫治療市場（依治療方式）

  • 藥品
    • 支氣管擴張劑
    • 類固醇
  • 外科手術
    • 肺移植
    • 肺減容手術
  • 治療方法
    • 氧氣療法
    • 呼吸復健

第8章按患者類型分類的肺氣腫治療市場

  • 成人用
  • 老年病
  • 小兒科

第9章依護理機構分類的肺氣腫治療市場

  • 診所
  • 居家護理
  • 醫院

第10章肺氣腫治療市場：依給藥途徑

  • 吸入
  • 口服
  • 胃腸外的

第11章 北美和南美肺氣腫治療市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第12章亞太地區肺氣腫治療市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第13章歐洲、中東和非洲的肺氣腫治療市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第14章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議
Product Code: MRR-1A1A064C021A

The Emphysema Treatment Market was valued at USD 6.40 billion in 2023, expected to reach USD 6.83 billion in 2024, and is projected to grow at a CAGR of 6.98%, to USD 10.27 billion by 2030.

The scope and definition of the emphysema treatment market encompass a range of medical interventions aimed at managing this chronic, irreversible lung condition, primarily characterized by damaged air sacs and obstructed airflow. Necessity arises as emphysema significantly impairs quality of life, demanding treatments that alleviate symptoms and enhance respiratory function. Applications involve both pharmacological approaches, such as bronchodilators and corticosteroids, and surgical interventions, like lung volume reduction surgery. The end-use scope includes hospitals, clinics, and home healthcare settings. Key growth drivers include an increasing prevalence of chronic obstructive pulmonary disease (COPD) due to aging populations and rising pollution levels, alongside advances in drug development and increasing patient preference for minimally invasive procedures. However, potential growth opportunities lie in expanding healthcare infrastructure in emerging markets and the development of novel therapies, such as regenerative medicines or personalized treatment plans bolstered by AI technologies. Addressing market limitations, challenges primarily stem from stringent regulatory requirements, high costs associated with advanced treatment modalities, and the inherent complexities of conducting clinical trials for respiratory diseases. Economic instability in certain regions could also impede market expansion. Innovative research areas include the development of wearable technology to monitor respiratory health, advances in telemedicine to facilitate remote patient management, and biomarker discovery to enable earlier diagnosis and tailored therapies. The market is dynamic, with a significant focus on technological advancements and a shift towards holistic and patient-centric care models. Companies aiming for business growth should invest in R&D to mitigate challenges and capitalize on emerging opportunities. Collaborations between pharmaceutical firms, healthcare providers, and technology companies could accelerate innovation, leading to better market penetration and improved patient outcomes. Emphasizing cost-effective and accessible treatment options will be crucial as the market continues to expand globally.

KEY MARKET STATISTICS
Base Year [2023] USD 6.40 billion
Estimated Year [2024] USD 6.83 billion
Forecast Year [2030] USD 10.27 billion
CAGR (%) 6.98%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Emphysema Treatment Market

The Emphysema Treatment Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing prevalence of smoking and rising pollution levels contributing to higher instances of emphysema
    • Advancements in diagnostic techniques and technologies facilitating early detection and treatment of emphysema
    • Growing geriatric population and higher susceptibility to respiratory diseases among the elderly
    • Rising healthcare expenditure and government initiatives supporting advanced treatment options for emphysema
  • Market Restraints
    • Stringent regulatory approvals process for new emphysema treatment drugs and devices causes delays in market entry
    • Low awareness and diagnosis rates of emphysema in rural areas hinder market growth
  • Market Opportunities
    • Increasing preference for minimally invasive surgical treatments for emphysema management
    • Growing demand for advanced drug delivery systems for targeted emphysema treatment
    • Rising awareness and screening programs for early detection of emphysema
  • Market Challenges
    • Regulatory hurdles and long approval times for new emphysema treatment therapies entering the market
    • Low patient adherence to prescribed treatment regimens due to complicated administration requirements

Porter's Five Forces: A Strategic Tool for Navigating the Emphysema Treatment Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Emphysema Treatment Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Emphysema Treatment Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Emphysema Treatment Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Emphysema Treatment Market

A detailed market share analysis in the Emphysema Treatment Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Emphysema Treatment Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Emphysema Treatment Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Emphysema Treatment Market

A strategic analysis of the Emphysema Treatment Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Emphysema Treatment Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., AstraZeneca plc, Bayer AG, Boehringer Ingelheim International GmbH, Chiesi Farmaceutici S.p.A., Cipla Limited, CSL Limited, Eli Lilly and Company, F. Hoffmann-La Roche AG, GlaxoSmithKline plc, Grifols S.A., Merck & Co., Inc., Mylan N.V., Novartis International AG, Pfizer Inc., Sanofi S.A., Sumitomo Dainippon Pharma Co., Ltd., Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited, and Teva Pharmaceutical Industries Ltd..

Market Segmentation & Coverage

This research report categorizes the Emphysema Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Inhalation Drugs, Intravenous Drugs, and Oral Drugs. The Inhalation Drugs is further studied across Anticholinergics, Long-acting Beta-agonists (LABAs), and Short-acting Beta-agonists (SABAs). The Oral Drugs is further studied across Corticosteroids and Phosphodiesterase-4 inhibitors (PDE4 Inhibitors).
  • Based on Treatment, market is studied across Medications, Surgeries, and Therapies. The Medications is further studied across Bronchodilators and Steroids. The Surgeries is further studied across Lung Transplant and Lung Volume Reduction Surgery. The Therapies is further studied across Oxygen Therapy and Pulmonary Rehabilitation.
  • Based on Patient Type, market is studied across Adult, Geriatric, and Pediatric.
  • Based on Care Settings, market is studied across Clinics, Home Care, and Hospitals.
  • Based on Route of Administration, market is studied across Inhalation, Oral, and Parenteral.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of smoking and rising pollution levels contributing to higher instances of emphysema
      • 5.1.1.2. Advancements in diagnostic techniques and technologies facilitating early detection and treatment of emphysema
      • 5.1.1.3. Growing geriatric population and higher susceptibility to respiratory diseases among the elderly
      • 5.1.1.4. Rising healthcare expenditure and government initiatives supporting advanced treatment options for emphysema
    • 5.1.2. Restraints
      • 5.1.2.1. Stringent regulatory approvals process for new emphysema treatment drugs and devices causes delays in market entry
      • 5.1.2.2. Low awareness and diagnosis rates of emphysema in rural areas hinder market growth
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing preference for minimally invasive surgical treatments for emphysema management
      • 5.1.3.2. Growing demand for advanced drug delivery systems for targeted emphysema treatment
      • 5.1.3.3. Rising awareness and screening programs for early detection of emphysema
    • 5.1.4. Challenges
      • 5.1.4.1. Regulatory hurdles and long approval times for new emphysema treatment therapies entering the market
      • 5.1.4.2. Low patient adherence to prescribed treatment regimens due to complicated administration requirements
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Emphysema Treatment Market, by Type

  • 6.1. Introduction
  • 6.2. Inhalation Drugs
    • 6.2.1. Anticholinergics
    • 6.2.2. Long-acting Beta-agonists (LABAs)
    • 6.2.3. Short-acting Beta-agonists (SABAs)
  • 6.3. Intravenous Drugs
  • 6.4. Oral Drugs
    • 6.4.1. Corticosteroids
    • 6.4.2. Phosphodiesterase-4 inhibitors (PDE4 Inhibitors)

7. Emphysema Treatment Market, by Treatment

  • 7.1. Introduction
  • 7.2. Medications
    • 7.2.1. Bronchodilators
    • 7.2.2. Steroids
  • 7.3. Surgeries
    • 7.3.1. Lung Transplant
    • 7.3.2. Lung Volume Reduction Surgery
  • 7.4. Therapies
    • 7.4.1. Oxygen Therapy
    • 7.4.2. Pulmonary Rehabilitation

8. Emphysema Treatment Market, by Patient Type

  • 8.1. Introduction
  • 8.2. Adult
  • 8.3. Geriatric
  • 8.4. Pediatric

9. Emphysema Treatment Market, by Care Settings

  • 9.1. Introduction
  • 9.2. Clinics
  • 9.3. Home Care
  • 9.4. Hospitals

10. Emphysema Treatment Market, by Route of Administration

  • 10.1. Introduction
  • 10.2. Inhalation
  • 10.3. Oral
  • 10.4. Parenteral

11. Americas Emphysema Treatment Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Emphysema Treatment Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Emphysema Treatment Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AbbVie Inc.
  • 2. AstraZeneca plc
  • 3. Bayer AG
  • 4. Boehringer Ingelheim International GmbH
  • 5. Chiesi Farmaceutici S.p.A.
  • 6. Cipla Limited
  • 7. CSL Limited
  • 8. Eli Lilly and Company
  • 9. F. Hoffmann-La Roche AG
  • 10. GlaxoSmithKline plc
  • 11. Grifols S.A.
  • 12. Merck & Co., Inc.
  • 13. Mylan N.V.
  • 14. Novartis International AG
  • 15. Pfizer Inc.
  • 16. Sanofi S.A.
  • 17. Sumitomo Dainippon Pharma Co., Ltd.
  • 18. Sun Pharmaceutical Industries Ltd.
  • 19. Takeda Pharmaceutical Company Limited
  • 20. Teva Pharmaceutical Industries Ltd.

LIST OF FIGURES

  • FIGURE 1. EMPHYSEMA TREATMENT MARKET RESEARCH PROCESS
  • FIGURE 2. EMPHYSEMA TREATMENT MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY PATIENT TYPE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY PATIENT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY CARE SETTINGS, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY CARE SETTINGS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS EMPHYSEMA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS EMPHYSEMA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES EMPHYSEMA TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES EMPHYSEMA TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC EMPHYSEMA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC EMPHYSEMA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. EMPHYSEMA TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. EMPHYSEMA TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. EMPHYSEMA TREATMENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. EMPHYSEMA TREATMENT MARKET DYNAMICS
  • TABLE 7. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY ANTICHOLINERGICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY LONG-ACTING BETA-AGONISTS (LABAS), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY SHORT-ACTING BETA-AGONISTS (SABAS), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY INTRAVENOUS DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY PHOSPHODIESTERASE-4 INHIBITORS (PDE4 INHIBITORS), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY MEDICATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY BRONCHODILATORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY STEROIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY SURGERIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY LUNG TRANSPLANT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY LUNG VOLUME REDUCTION SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY OXYGEN THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY PULMONARY REHABILITATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY ADULT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY CARE SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY HOME CARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY PARENTERAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 43. AMERICAS EMPHYSEMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. AMERICAS EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 45. AMERICAS EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 46. AMERICAS EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 47. AMERICAS EMPHYSEMA TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 48. AMERICAS EMPHYSEMA TREATMENT MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 49. AMERICAS EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 50. AMERICAS EMPHYSEMA TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. AMERICAS EMPHYSEMA TREATMENT MARKET SIZE, BY CARE SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 52. AMERICAS EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 53. AMERICAS EMPHYSEMA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 54. ARGENTINA EMPHYSEMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. ARGENTINA EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 56. ARGENTINA EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 57. ARGENTINA EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 58. ARGENTINA EMPHYSEMA TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 59. ARGENTINA EMPHYSEMA TREATMENT MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 60. ARGENTINA EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 61. ARGENTINA EMPHYSEMA TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. ARGENTINA EMPHYSEMA TREATMENT MARKET SIZE, BY CARE SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 63. ARGENTINA EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 64. BRAZIL EMPHYSEMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. BRAZIL EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 66. BRAZIL EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 67. BRAZIL EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 68. BRAZIL EMPHYSEMA TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 69. BRAZIL EMPHYSEMA TREATMENT MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 70. BRAZIL EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 71. BRAZIL EMPHYSEMA TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. BRAZIL EMPHYSEMA TREATMENT MARKET SIZE, BY CARE SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 73. BRAZIL EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 74. CANADA EMPHYSEMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. CANADA EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 76. CANADA EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 77. CANADA EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 78. CANADA EMPHYSEMA TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 79. CANADA EMPHYSEMA TREATMENT MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 80. CANADA EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 81. CANADA EMPHYSEMA TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. CANADA EMPHYSEMA TREATMENT MARKET SIZE, BY CARE SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 83. CANADA EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 84. MEXICO EMPHYSEMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. MEXICO EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 86. MEXICO EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 87. MEXICO EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 88. MEXICO EMPHYSEMA TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 89. MEXICO EMPHYSEMA TREATMENT MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 90. MEXICO EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 91. MEXICO EMPHYSEMA TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. MEXICO EMPHYSEMA TREATMENT MARKET SIZE, BY CARE SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 93. MEXICO EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 94. UNITED STATES EMPHYSEMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. UNITED STATES EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED STATES EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED STATES EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED STATES EMPHYSEMA TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED STATES EMPHYSEMA TREATMENT MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED STATES EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED STATES EMPHYSEMA TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. UNITED STATES EMPHYSEMA TREATMENT MARKET SIZE, BY CARE SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 103. UNITED STATES EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 104. UNITED STATES EMPHYSEMA TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 105. ASIA-PACIFIC EMPHYSEMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. ASIA-PACIFIC EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 107. ASIA-PACIFIC EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 108. ASIA-PACIFIC EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 109. ASIA-PACIFIC EMPHYSEMA TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 110. ASIA-PACIFIC EMPHYSEMA TREATMENT MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 111. ASIA-PACIFIC EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 112. ASIA-PACIFIC EMPHYSEMA TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. ASIA-PACIFIC EMPHYSEMA TREATMENT MARKET SIZE, BY CARE SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC EMPHYSEMA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 116. AUSTRALIA EMPHYSEMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. AUSTRALIA EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 118. AUSTRALIA EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 119. AUSTRALIA EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 120. AUSTRALIA EMPHYSEMA TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 121. AUSTRALIA EMPHYSEMA TREATMENT MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 122. AUSTRALIA EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 123. AUSTRALIA EMPHYSEMA TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. AUSTRALIA EMPHYSEMA TREATMENT MARKET SIZE, BY CARE SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 125. AUSTRALIA EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 126. CHINA EMPHYSEMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. CHINA EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 128. CHINA EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 129. CHINA EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 130. CHINA EMPHYSEMA TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 131. CHINA EMPHYSEMA TREATMENT MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 132. CHINA EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 133. CHINA EMPHYSEMA TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. CHINA EMPHYSEMA TREATMENT MARKET SIZE, BY CARE SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 135. CHINA EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 136. INDIA EMPHYSEMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. INDIA EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 138. INDIA EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 139. INDIA EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 140. INDIA EMPHYSEMA TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 141. INDIA EMPHYSEMA TREATMENT MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 142. INDIA EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 143. INDIA EMPHYSEMA TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. INDIA EMPHYSEMA TREATMENT MARKET SIZE, BY CARE SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 145. INDIA EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 146. INDONESIA EMPHYSEMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. INDONESIA EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 148. INDONESIA EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 149. INDONESIA EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 150. INDONESIA EMPHYSEMA TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 151. INDONESIA EMPHYSEMA TREATMENT MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 152. INDONESIA EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 153. INDONESIA EMPHYSEMA TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. INDONESIA EMPHYSEMA TREATMENT MARKET SIZE, BY CARE SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 155. INDONESIA EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 156. JAPAN EMPHYSEMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 157. JAPAN EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 158. JAPAN EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 159. JAPAN EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 160. JAPAN EMPHYSEMA TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 161. JAPAN EMPHYSEMA TREATMENT MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 162. JAPAN EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 163. JAPAN EMPHYSEMA TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. JAPAN EMPHYSEMA TREATMENT MARKET SIZE, BY CARE SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 165. JAPAN EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 166. MALAYSIA EMPHYSEMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 167. MALAYSIA EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 168. MALAYSIA EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 169. MALAYSIA EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 170. MALAYSIA EMPHYSEMA TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 171. MALAYSIA EMPHYSEMA TREATMENT MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 172. MALAYSIA EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 173. MALAYSIA EMPHYSEMA TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. MALAYSIA EMPHYSEMA TREATMENT MARKET SIZE, BY CARE SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 175. MALAYSIA EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 176. PHILIPPINES EMPHYSEMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 177. PHILIPPINES EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 178. PHILIPPINES EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 179. PHILIPPINES EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 180. PHILIPPINES EMPHYSEMA TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 181. PHILIPPINES EMPHYSEMA TREATMENT MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 182. PHILIPPINES EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 183. PHILIPPINES EMPHYSEMA TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. PHILIPPINES EMPHYSEMA TREATMENT MARKET SIZE, BY CARE SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 185. PHILIPPINES EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 186. SINGAPORE EMPHYSEMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 187. SINGAPORE EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 188. SINGAPORE EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 189. SINGAPORE EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 190. SINGAPORE EMPHYSEMA TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 191. SINGAPORE EMPHYSEMA TREATMENT MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 192. SINGAPORE EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 193. SINGAPORE EMPHYSEMA TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 194. SINGAPORE EMPHYSEMA TREATMENT MARKET SIZE, BY CARE SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 195. SINGAPORE EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 196. SOUTH KOREA EMPHYSEMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 197. SOUTH KOREA EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 198. SOUTH KOREA EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 199. SOUTH KOREA EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 200. SOUTH KOREA EMPHYSEMA TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 201. SOUTH KOREA EMPHYSEMA TREATMENT MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH KOREA EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH KOREA EMPHYSEMA TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH KOREA EMPHYSEMA TREATMENT MARKET SIZE, BY CARE SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH KOREA EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 206. TAIWAN EMPHYSEMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 207. TAIWAN EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 208. TAIWAN EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 209. TAIWAN EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 210. TAIWAN EMPHYSEMA TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 211. TAIWAN EMPHYSEMA TREATMENT MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 212. TAIWAN EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 213. TAIWAN EMPHYSEMA TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 214. TAIWAN EMPHYSEMA TREATMENT MARKET SIZE, BY CARE SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 215. TAIWAN EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 216. THAILAND EMPHYSEMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 217. THAILAND EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 218. THAILAND EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 219. THAILAND EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 220. THAILAND EMPHYSEMA TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 221. THAILAND EMPHYSEMA TREATMENT MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 222. THAILAND EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 223. THAILAND EMPHYSEMA TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 224. THAILAND EMPHYSEMA TREATMENT MARKET SIZE, BY CARE SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 225. THAILAND EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 226. VIETNAM EMPHYSEMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 227. VIETNAM EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 228. VIETNAM EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 229. VIETNAM EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 230. VIETNAM EMPHYSEMA TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 231. VIETNAM EMPHYSEMA TREATMENT MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 232. VIETNAM EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 233. VIETNAM EMPHYSEMA TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 234. VIETNAM EMPHYSEMA TREATMENT MARKET SIZE, BY CARE SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 235. VIETNAM EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 236. EUROPE, MIDDLE EAST & AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 237. EUROPE, MIDDLE EAST & AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 238. EUROPE, MIDDLE EAST & AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 239. EUROPE, MIDDLE EAST & AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 240. EUROPE, MIDDLE EAST & AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 241. EUROPE, MIDDLE EAST & AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 242. EUROPE, MIDDLE EAST & AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 243. EUROPE, MIDDLE EAST & AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 244. EUROPE, MIDDLE EAST & AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY CARE SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 245. EUROPE, MIDDLE EAST & AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 246. EUROPE, MIDDLE EAST & AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 247. DENMARK EMPHYSEMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 248. DENMARK EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 249. DENMARK EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 250. DENMARK EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 251. DENMARK EMPHYSEMA TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 252. DENMARK EMPHYSEMA TREATMENT MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 253. DENMARK EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 254. DENMARK EMPHYSEMA TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 255. DENMARK EMPHYSEMA TREATMENT MARKET SIZE, BY CARE SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 256. DENMARK EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 257. EGYPT EMPHYSEMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 258. EGYPT EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 259. EGYPT EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 260. EGYPT EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 261. EGYPT EMPHYSEMA TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 262. EGYPT EMPHYSEMA TREATMENT MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 263. EGYPT EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 264. EGYPT EMPHYSEMA TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 265. EGYPT EMPHYSEMA TREATMENT MARKET SIZE, BY CARE SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 266. EGYPT EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 267. FINLAND EMPHYSEMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 268. FINLAND EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 269. FINLAND EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 270. FINLAND EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 271. FINLAND EMPHYSEMA TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 272. FINLAND EMPHYSEMA TREATMENT MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 273. FINLAND EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 274. FINLAND EMPHYSEMA TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 275. FINLAND EMPHYSEMA TREATMENT MARKET SIZE, BY CARE SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 276. FINLAND EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 277. FRANCE EMPHYSEMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 278. FRANCE EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 279. FRANCE EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 280. FRANCE EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 281. FRANCE EMPHYSEMA TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 282. FRANCE EMPHYSEMA TREATMENT MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 283. FRANCE EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 284. FRANCE EMPHYSEMA TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 285. FRANCE EMPHYSEMA TREATMENT MARKET SIZE, BY CARE SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 286. FRANCE EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 287. GERMANY EMPHYSEMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 288. GERMANY EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 289. GERMANY EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 290. GERMANY EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 291. GERMANY EMPHYSEMA TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 292. GERMANY EMPHYSEMA TREATMENT MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 293. GERMANY EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 294. GERMANY EMPHYSEMA TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 295. GERMANY EMPHYSEMA TREATMENT MARKET SIZE, BY CARE SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 296. GERMANY EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 297. ISRAEL EMPHYSEMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 298. ISRAEL EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 299. ISRAEL EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 300. ISRAEL EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 301. ISRAEL EMPHYSEMA TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 302. ISRAEL EMPHYSEMA TREATMENT MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 303. ISRAEL EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 304. ISRAEL EMPHYSEMA TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 305. ISRAEL EMPHYSEMA TREATMENT MARKET SIZE, BY CARE SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 306. ISRAEL EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 307. ITALY EMPHYSEMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 308. ITALY EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 309. ITALY EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 310. ITALY EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 311. ITALY EMPHYSEMA TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 312. ITALY EMPHYSEMA TREATMENT MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 313. ITALY EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 314. ITALY EMPHYSEMA TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 315. ITALY EMPHYSEMA TREATMENT MARKET SIZE, BY CARE SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 316. ITALY EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 317. NETHERLANDS EMPHYSEMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 318. NETHERLANDS EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 319. NETHERLANDS EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 320. NETHERLANDS EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 321. NETHERLANDS EMPHYSEMA TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 322. NETHERLANDS EMPHYSEMA TREATMENT MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 323. NETHERLANDS EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 324. NETHERLANDS EMPHYSEMA TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 325. NETHERLANDS EMPHYSEMA TREATMENT MARKET SIZE, BY CARE SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 326. NETHERLANDS EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 327. NIGERIA EMPHYSEMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 328. NIGERIA EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 329. NIGERIA EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 330. NIGERIA EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 331. NIGERIA EMPHYSEMA TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 332. NIGERIA EMPHYSEMA TREATMENT MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 333. NIGERIA EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 334. NIGERIA EMPHYSEMA TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 335. NIGERIA EMPHYSEMA TREATMENT MARKET SIZE, BY CARE SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 336. NIGERIA EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 337. NORWAY EMPHYSEMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 338. NORWAY EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 339. NORWAY EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 340. NORWAY EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 341. NORWAY EMPHYSEMA TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 342. NORWAY EMPHYSEMA TREATMENT MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 343. NORWAY EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 344. NORWAY EMPHYSEMA TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 345. NORWAY EMPHYSEMA TREATMENT MARKET SIZE, BY CARE SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 346. NORWAY EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 347. POLAND EMPHYSEMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 348. POLAND EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 349. POLAND EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL